BCR-ABL tyrosine kinase inhibitors

S 2 Pill - orange capsule-shape

Pill with imprint S 2 is Orange, Capsule-shape and has been identified as Imatinib Mesylate 400 mg. It is supplied by Ascend Laboratories LLC.

Imatinib is used in the treatment of Chronic Myelogenous Leukemia; Chronic Eosinophilic Leukemia; Acute Lymphoblastic Leukemia; Dermatofibrosarcoma Protuberans; Gastrointestinal Stromal Tumor and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Imatinib 400 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Imatinib (Imatinib [ im-ma-ta-nib ])-S 2-400 mg-Orange-Capsule-shape
Imatinib (Imatinib [ im-ma-ta-nib ])-S 2-400 mg-Orange-Capsule-shape
Imatinib (Imatinib [ im-ma-ta-nib ])-S 2-400 mg-Orange-Capsule-shape
Imatinib (Imatinib [ im-ma-ta-nib ])-S 2-400 mg-Orange-Capsule-shape

Imatinib
Generic Name: imatinib [ im-ma-ta-nib ]
Imprint: S 2
Strength: 400 mg
Color: Orange
Size: N/A
Shape: Capsule-shape
Availability: Prescription only
Drug Class: BCR-ABL tyrosine kinase inhibitors
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 67877-0634
Inactive Ingredients:
Latest News
Related Drugs